For investors seeking momentum, Health Care Select Sector SPDR ETF (XLV Quick QuoteXLV - Free Report) is probably on the radar. The fund just hit a 52-week high and is up 15.5% from its 52-week low price of $122.59/share.

But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed:

XLV in Focus

The underlying Health Care Select Sector Index includes companies from the following industries: pharmaceuticals; health care providers & services; health care equipment & supplies; biotechnology; life sciences tools & services; and health care technology. It charges 10 bps in annual fees.

Why the Move?

The healthcare sector has been an area to watch lately, with the stocks staging a strong comeback at the start of 2024. The gains are driven by multibillion-dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.

More Gains Ahead?

Currently, XLV has a Zacks ETF Rank #1 (Strong Buy) with a Medium risk outlook, suggesting that the outperformance could continue in the months ahead.